RAPP
Rapport Therapeutics, Inc.
27.02
+1.06 (+4.08%)
52w low 22.06
52.93 high
16.1% of range
Financial Analysis
| (USD) | Mar 25 | Sep 25 | Dec 25 | Mar 26 | Jun 26 | Sep 26 | Trend |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | -- | 251.36M | 52.65M | 78.06M | 63.61M | 74.75M | |
| Receivables | -- | -- | -- | 58.00K | 293.00K | 171.00K | |
| Current Assets | -- | 520.66M | 498.56M | 484.69M | 446.86M | 407.38M | |
| Net PP&E | -- | 13.60M | 12.88M | 11.85M | 11.07M | 10.08M | |
| Total Assets | -- | 535.32M | 512.43M | 497.60M | 458.98M | 418.56M | |
| Current Liabilities | -- | 14.32M | 19.05M | 17.90M | 28.42M | 20.30M | |
| Total Debt | -- | 11.87M | 11.48M | 10.80M | 10.11M | 9.39M | |
| Total Liabilities | -- | 23.71M | 27.78M | 26.09M | 36.06M | 27.37M | |
| Retained Earnings | -- | -201.47M | -235.23M | -255.09M | -311.70M | -351.94M | |
| Shareholders Equity | -- | 511.62M | 484.65M | 471.51M | 422.93M | 391.19M | |
| Working Capital | -- | 506.34M | 479.51M | 466.80M | 418.43M | 387.08M | |
| Shares Outstanding | -- | 47.65M | 47.77M | 47.81M | 47.96M | 48.09M |
Revenue CAGR
--
Net Income CAGR
--
EPS CAGR
--
FCF CAGR
--
Revenue YoY
--